2-Amino-7-(Dimethylamino)-4-[3-(Trifluoromethyl)Phenyl]-4H-Chromene-3-Carbonitrile
CAS: 331859-86-0
Ref. 3D-FA100907
5mg | Nachfragen | |
10mg | Nachfragen | |
25mg | Nachfragen |
Produktinformation
- 2-Amino-3-cyano-7-dimethylamino-4-(3-trifluoromethylphenyl)-4H-chromene
- Chromeceptin
2-Amino-7-(dimethylamino)-4-[3-(trifluoromethyl)phenyl]-4H-chromene-3-carbonitrile, also known as Fostamatinib, is an experimental drug that was originally developed to treat cancer. It has shown potential to treat type 2 diabetes by inhibiting the growth of pancreatic beta cells. Fostamatinib binds to insulin-like growth factor 1 (IGF1), a molecule that is involved in cell proliferation and differentiation. This binding prevents IGF1 from binding to its receptor, thus preventing the signal transducer and activator of transcription 3 (STAT3) protein from phosphorylation. STAT3 activation is required for the production of proinflammatory cytokines such as IL-6 and TNFα. STAT3 inhibition has been shown to reduce inflammation in animal models and may be beneficial for treating inflammatory diseases such as type 2 diabetes.
Chemische Eigenschaften
Technische Anfrage zu: 3D-FA100907 2-Amino-7-(Dimethylamino)-4-[3-(Trifluoromethyl)Phenyl]-4H-Chromene-3-Carbonitrile
Wenn Sie ein Angebot anfordern oder eine Bestellung aufgeben möchten, legen Sie stattdessen die gewünschten Produkte in Ihren Warenkorb und fordern Sie dann ein Angebot oder eine Bestellung an aus dem Warenkorb. Es ist schneller, billiger und Sie können von den verfügbaren Rabatten und anderen Vorteilen profitieren.